Ipsen SA Current Valuation vs. EBITDA
| I7G Stock | EUR 108.30 0.60 0.55% |
For Ipsen SA profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ipsen SA to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ipsen SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ipsen SA's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ipsen SA over time as well as its relative position and ranking within its peers.
Ipsen |
Ipsen SA EBITDA vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Ipsen SA's current stock value. Our valuation model uses many indicators to compare Ipsen SA value to that of its competitors to determine the firm's financial worth. Ipsen SA is rated fourth overall in current valuation category among its peers. It is currently regarded as number one stock in ebitda category among its peers totaling about 0.13 of EBITDA per Current Valuation. The ratio of Current Valuation to EBITDA for Ipsen SA is roughly 7.97 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ipsen SA's earnings, one of the primary drivers of an investment's value.Ipsen Current Valuation vs. Competition
Ipsen SA is rated fourth overall in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Drug Manufacturers - Specialty & Generic industry is currently estimated at about 74.19 Billion. Ipsen SA retains roughly 8.46 Billion in current valuation claiming about 11% of equities under Drug Manufacturers - Specialty & Generic industry.
Ipsen EBITDA vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Ipsen SA |
| = | 8.46 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Ipsen SA |
| = | 1.06 B |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Ipsen EBITDA Comparison
Ipsen SA is currently under evaluation in ebitda category among its peers.
Ipsen SA Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Ipsen SA, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Ipsen SA will eventually generate negative long term returns. The profitability progress is the general direction of Ipsen SA's change in net profit over the period of time. It can combine multiple indicators of Ipsen SA, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Ipsen S.A. operates as a biopharmaceutical company worldwide. Ipsen S.A. was founded in 1929 and is headquartered in Boulogne-Billancourt, France. IPSEN S operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 5700 people.
Ipsen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Ipsen SA. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ipsen SA position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ipsen SA's important profitability drivers and their relationship over time.
Use Ipsen SA in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ipsen SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ipsen SA will appreciate offsetting losses from the drop in the long position's value.Ipsen SA Pair Trading
Ipsen SA Pair Trading Analysis
The ability to find closely correlated positions to Ipsen SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ipsen SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ipsen SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ipsen SA to buy it.
The correlation of Ipsen SA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ipsen SA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ipsen SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ipsen SA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Ipsen SA position
In addition to having Ipsen SA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Blockchain Thematic Idea Now
Blockchain
Companies across muliple sectors and different technology products and services that are engaged in some capacity with blockchain technolgoy or evolution of cryptocurrency. The Blockchain theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Blockchain Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Ipsen Stock
To fully project Ipsen SA's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Ipsen SA at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Ipsen SA's income statement, its balance sheet, and the statement of cash flows.